The endothelial transcription factor erg promotes vascular stability and growth through Wnt/β-catenin signaling

Developmental Cell

Volumn 32, Issue 1, 2015, Pages 82-96

  Birdsey, Graeme M ^a   Shah, Aarti V ^a   Dufton, Neil ^a   Reynolds, Louise E ^b   Almagro, Lourdes Osuna ^a   Yang, Youwen ^a   Aspalter, Irene M ^c   Khan, Samia T ^a   Mason, Justin C ^a   Dejana, Elisabetta ^d   Göttgens, Berthold ^e   Hodivala Dilke, Kairbaan ^b   Gerhardt, Holger ^c   Adams, Ralf H ^f   Randi, Anna M ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^d FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^f UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; FRIZZLED PROTEIN; LITHIUM CHLORIDE; PROTEIN FRIZZLED 4; TRANSCRIPTION FACTOR ERG; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL CADHERIN; WNT PROTEIN; CADHERIN; CRE RECOMBINASE; ERG PROTEIN, MOUSE; FZD4 PROTEIN, MOUSE; INTEGRASE; LEUKOCYTE ANTIGEN; ONCOPROTEIN; TRANSCRIPTION FACTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A, MOUSE; VASCULOTROPIN A;

ADULT; ANGIOGENESIS; ARTICLE; BLOOD VESSEL PERMEABILITY; CARDIOVASCULAR MALFORMATION; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; ENDOTHELIUM CELL; ERG GENE; FEMALE; GENE; IN VIVO STUDY; LETHALITY; MOUSE; NONHUMAN; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STABILITY; RETINA DEVELOPMENT; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM; ANIMAL; CELL CULTURE; CHROMATIN IMMUNOPRECIPITATION; CYTOLOGY; GENETICS; HUMAN; LUNG; METABOLISM; PHYSIOLOGY; PREGNANCY; REAL TIME POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE; UMBILICAL VEIN ENDOTHELIAL CELL; WESTERN BLOTTING;

MUS;

ANIMALS; ANTIGENS, CD; BETA CATENIN; BLOTTING, WESTERN; CADHERINS; CELLS, CULTURED; CHROMATIN IMMUNOPRECIPITATION; ENDOTHELIUM, VASCULAR; FEMALE; FRIZZLED RECEPTORS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INTEGRASES; LUNG; MICE; MICE, TRANSGENIC; NEOVASCULARIZATION, PHYSIOLOGIC; ONCOGENE PROTEINS; PREGNANCY; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WNT PROTEINS;

EID: 84922364577     PISSN: 15345807     EISSN: 18781551     Source Type: Journal    
DOI: 10.1016/j.devcel.2014.11.016     Document Type: Article

References (53)

1. Alastalo T.P., Li M., Perez Vde.J., Pham D., Sawada H., Wang J.K., Koskenvuo M., Wang L., Freeman B.A., Chang H.Y., Rabinovitch M. Disruption of PPARγ/β-catenin-mediated regulation of apelin impairs BMP-induced mouse and human pulmonary arterial EC survival. J.Clin. Invest. 2011, 121:3735-3746.
2. Baltzinger M., Mager-Heckel A.M., Remy P. Xl erg: expression pattern and overexpression during development plead for a role in endothelial cell differentiation. Dev. Dyn. 1999, 216:420-433.
3. Birdsey G.M., Dryden N.H., Amsellem V., Gebhardt F., Sahnan K., Haskard D.O., Dejana E., Mason J.C., Randi A.M. Transcription factor Erg regulates angiogenesis and endothelial apoptosis through VE-cadherin. Blood 2008, 111:3498-3506.
4. Birdsey G.M., Dryden N.H., Shah A.V., Hannah R., Hall M.D., Haskard D.O., Parsons M., Mason J.C., Zvelebil M., Gottgens B., et al. The transcription factor Erg regulates expression of histone deacetylase 6 and multiple pathways involved in endothelial cell migration and angiogenesis. Blood 2012, 119:894-903.
5. Birney E., Stamatoyannopoulos J.A., Dutta A., Guigó R., Gingeras T.R., Margulies E.H., Weng Z., Snyder M., Dermitzakis E.T., Thurman R.E., et al. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 2007, 447:799-816. ENCODE Project Consortium, NISC Comparative Sequencing ProgramNISC Comparative Sequencing Program, Baylor College of Medicine Human Genome Sequencing CenterBaylor College of Medicine Human Genome Sequencing Center, Washington University Genome Sequencing CenterWashington University Genome Sequencing Center, Broad InstituteBroad Institute, Children's Hospital Oakland Research InstituteChildren's Hospital Oakland Research Institute.
6. Bussolati B., Ahmed A., Pemberton H., Landis R.C., Di Carlo F., Haskard D.O., Mason J.C. Bifunctional role for VEGF-induced heme oxygenase-1 invivo: induction of angiogenesis and inhibition of leukocytic infiltration. Blood 2004, 103:761-766.
7. Cattelino A., Liebner S., Gallini R., Zanetti A., Balconi G., Corsi A., Bianco P., Wolburg H., Moore R., Oreda B., et al. The conditional inactivation of the beta-catenin gene in endothelial cells causes a defective vascular pattern and increased vascular fragility. J.Cell Biol. 2003, 162:1111-1122.
8. Corada M., Nyqvist D., Orsenigo F., Caprini A., Giampietro C., Taketo M.M., Iruela-Arispe M.L., Adams R.H., Dejana E. The Wnt/beta-catenin pathway modulates vascular remodeling and specification by upregulating Dll4/Notch signaling. Dev. Cell 2010, 18:938-949.
9. Dejana E. The role of wnt signaling in physiological and pathological angiogenesis. Circ. Res. 2010, 107:943-952.
10. Franco C.A., Liebner S., Gerhardt H. Vascular morphogenesis: a Wnt for every vessel?. Curr. Opin. Genet. Dev. 2009, 19:476-483.
11. Gerhardt H., Wolburg H., Redies C. N-cadherin mediates pericytic-endothelial interaction during brain angiogenesis in the chicken. Dev. Dyn. 2000, 218:472-479.
12. Giampietro C., Taddei A., Corada M., Sarra-Ferraris G.M., Alcalay M., Cavallaro U., Orsenigo F., Lampugnani M.G., Dejana E. Overlapping and divergent signaling pathways of N-cadherin and VE-cadherin in endothelial cells. Blood 2012, 119:2159-2170.
13. Giles R.H., van Es J.H., Clevers H. Caught up in a Wnt storm: Wnt signaling in cancer. Biochim. Biophys. Acta 2003, 1653:1-24.
14. Goodwin A.M., D'Amore P.A. Wnt signaling in the vasculature. Angiogenesis 2002, 5:1-9.
15. Goodwin A.M., Sullivan K.M., D'Amore P.A. Cultured endothelial cells display endogenous activation of the canonical Wnt signaling pathway and express multiple ligands, receptors, and secreted modulators of Wnt signaling. Dev. Dyn. 2006, 235:3110-3120.
16. Gory S., Dalmon J., Prandini M.H., Kortulewski T., de Launoit Y., Huber P. Requirement of a GT box (Sp1 site) and two Ets binding sites for vascular endothelial cadherin gene transcription. J.Biol. Chem. 1998, 273:6750-6755.
17. Griffin C.T., Curtis C.D., Davis R.B., Muthukumar V., Magnuson T. The chromatin-remodeling enzyme BRG1 modulates vascular Wnt signaling at two levels. Proc. Natl. Acad. Sci. USA 2011, 108:2282-2287.
18. Gupta S., Iljin K., Sara H., Mpindi J.P., Mirtti T., Vainio P., Rantala J., Alanen K., Nees M., Kallioniemi O. FZD4 as a mediator of ERG oncogene-induced WNT signaling and epithelial-to-mesenchymal transition in human prostate cancer cells. Cancer Res. 2010, 70:6735-6745.
19. Hellström M., Gerhardt H., Kalén M., Li X., Eriksson U., Wolburg H., Betsholtz C. Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis. J.Cell Biol. 2001, 153:543-553.
20. Jain R.K. Molecular regulation of vessel maturation. Nat. Med. 2003, 9:685-693.
21. Jho E.H., Zhang T., Domon C., Joo C.K., Freund J.N., Costantini F. Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol. Cell. Biol. 2002, 22:1172-1183.
22. Kisanuki Y.Y., Hammer R.E., Miyazaki J., Williams S.C., Richardson J.A., Yanagisawa M. Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis invivo. Dev. Biol. 2001, 230:230-242.
23. Korinek V., Barker N., Morin P.J., van Wichen D., de Weger R., Kinzler K.W., Vogelstein B., Clevers H. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science 1997, 275:1784-1787.
24. Korn C., Scholz B., Hu J., Srivastava K., Wojtarowicz J., Arnsperger T., Adams R.H., Boutros M., Augustin H.G., Augustin I. Endothelial cell-derived non-canonical Wnt ligands control vascular pruning in angiogenesis. Development 2014, 141:1757-1766.
25. Li Y., Kong D., Wang Z., Ahmad A., Bao B., Padhye S., Sarkar F.H. Inactivation of AR/TMPRSS2-ERG/Wnt signaling networks attenuates the aggressive behavior of prostate cancer cells. Cancer Prev. Res. (Phila.) 2011, 4:1495-1506.
26. Liebner S., Corada M., Bangsow T., Babbage J., Taddei A., Czupalla C.J., Reis M., Felici A., Wolburg H., Fruttiger M., et al. Wnt/beta-catenin signaling controls development of the blood-brain barrier. J.Cell Biol. 2008, 183:409-417.
27. Liu F., Patient R. Genome-wide analysis of the zebrafish ETS family identifies three genes required for hemangioblast differentiation or angiogenesis. Circ. Res. 2008, 103:1147-1154.
28. Loughran S.J., Kruse E.A., Hacking D.F., de Graaf C.A., Hyland C.D., Willson T.A., Henley K.J., Ellis S., Voss A.K., Metcalf D., et al. The transcription factor Erg is essential for definitive hematopoiesis and the function of adult hematopoietic stem cells. Nat. Immunol. 2008, 9:810-819.
29. Masckauchan T.N., Shawber C.J., Funahashi Y., Li C.M., Kitajewski J. Wnt/beta-catenin signaling induces proliferation, survival and interleukin-8 in human endothelial cells. Angiogenesis 2005, 8:43-51.
30. McLaughlin F., Ludbrook V.J., Cox J., von Carlowitz I., Brown S., Randi A.M. Combined genomic and antisense analysis reveals that the transcription factor Erg is implicated in endothelial cell differentiation. Blood 2001, 98:3332-3339.
31. Mochmann L.H., Bock J., Ortiz-Tánchez J., Schlee C., Bohne A., Neumann K., Hofmann W.K., Thiel E., Baldus C.D. Genome-wide screen reveals WNT11, a non-canonical WNT gene, as a direct target of ETS transcription factor ERG. Oncogene 2011, 30:2044-2056.
32. Nakatsu M.N., Davis J., Hughes C.C. Optimized fibrin gel bead assay for the study of angiogenesis. J.Vis. Exp. 2007, 186.
33. Phng L.K., Potente M., Leslie J.D., Babbage J., Nyqvist D., Lobov I., Ondr J.K., Rao S., Lang R.A., Thurston G., Gerhardt H. Nrarp coordinates endothelial Notch and Wnt signaling to control vessel density in angiogenesis. Dev. Cell 2009, 16:70-82.
34. Pitulescu M.E., Schmidt I., Benedito R., Adams R.H. Inducible gene targeting in the neonatal vasculature and analysis of retinal angiogenesis in mice. Nat. Protoc. 2010, 5:1518-1534.
35. Randi A.M., Sperone A., Dryden N.H., Birdsey G.M. Regulation of angiogenesis by ETS transcription factors. Biochem. Soc. Trans. 2009, 37:1248-1253.
36. Reginato S., Gianni-Barrera R., Banfi A. Taming of the wild vessel: promoting vessel stabilization for safe therapeutic angiogenesis. Biochem. Soc. Trans. 2011, 39:1654-1658.
37. Reis M., Liebner S. Wnt signaling in the vasculature. Exp. Cell Res. 2013, 319:1317-1323.
38. Reynolds L.E., Wyder L., Lively J.C., Taverna D., Robinson S.D., Huang X., Sheppard D., Hynes R.O., Hodivala-Dilke K.M. Enhanced pathological angiogenesis in mice lacking beta3 integrin or beta3 and beta5 integrins. Nat. Med. 2002, 8:27-34.
39. Roose J., Huls G., van B.M., Moerer P., van der Horn K., Goldschmeding R., Logtenberg T., Clevers H. Synergy between tumor suppressor APC and the beta-catenin-Tcf4 target Tcf1. Science 1999, 285:1923-1926.
40. Shtutman M., Zhurinsky J., Simcha I., Albanese C., D'Amico M., Pestell R., Ben-Ze'ev A. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc. Natl. Acad. Sci. USA 1999, 96:5522-5527.
41. Sperone A., Dryden N.H., Birdsey G.M., Madden L., Johns M., Evans P.C., Mason J.C., Haskard D.O., Boyle J.J., Paleolog E.M., Randi A.M. The transcription factor Erg inhibits vascular inflammation by repressing NF-kappaB activation and proinflammatory gene expression in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 2011, 31:142-150.
42. Stambolic V., Ruel L., Woodgett J.R. Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells. Curr. Biol. 1996, 6:1664-1668.
43. Vijayaraj P., Le Bras A., Mitchell N., Kondo M., Juliao S., Wasserman M., Beeler D., Spokes K., Aird W.C., Baldwin H.S., Oettgen P. Erg is a crucial regulator of endocardial-mesenchymal transformation during cardiac valve morphogenesis. Development 2012, 139:3973-3985.
44. Wang X., Xiao Y., Mou Y., Zhao Y., Blankesteijn W.M., Hall J.L. A role for the beta-catenin/T-cell factor signaling cascade in vascular remodeling. Circ. Res. 2002, 90:340-347.
45. Wang Y., Nakayama M., Pitulescu M.E., Schmidt T.S., Bochenek M.L., Sakakibara A., Adams S., Davy A., Deutsch U., Lüthi U., et al. Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis. Nature 2010, 465:483-486.
46. Wu L., Zhao J.C., Kim J., Jin H.J., Wang C.Y., Yu J. ERG is a critical regulator of Wnt/LEF1 signaling in prostate cancer. Cancer Res. 2013, 73:6068-6079.
47. Wythe J.D., Dang L.T., Devine W.P., Boudreau E., Artap S.T., He D., Schachterle W., Stainier D.Y., Oettgen P., Black B.L., et al. ETS factors regulate Vegf-dependent arterial specification. Dev. Cell 2013, 26:45-58.
48. Xu Q., Wang Y., Dabdoub A., Smallwood P.M., Williams J., Woods C., Kelley M.W., Jiang L., Tasman W., Zhang K., Nathans J. Vascular development in the retina and inner ear: control by Norrin and Frizzled-4, a high-affinity ligand-receptor pair. Cell 2004, 116:883-895.
49. Ye X., Wang Y., Cahill H., Yu M., Badea T.C., Smallwood P.M., Peachey N.S., Nathans J. Norrin, frizzled-4, and Lrp5 signaling in endothelial cells controls a genetic program for retinal vascularization. Cell 2009, 139:285-298.
50. Yuan L., Nikolova-Krstevski V., Zhan Y., Kondo M., Bhasin M., Varghese L., Yano K., Carman C.V., Aird W.C., Oettgen P. Antiinflammatory effects of the ETS factor ERG in endothelial cells are mediated through transcriptional repression of the interleukin-8 gene. Circ. Res. 2009, 104:1049-1057.
51. Yuan L., Le Bras A., Sacharidou A., Itagaki K., Zhan Y., Kondo M., Carman C.V., Davis G.E., Aird W.C., Oettgen P. ETS-related gene (ERG) controls endothelial cell permeability via transcriptional regulation of the claudin 5 (CLDN5) gene. J.Biol. Chem. 2012, 287:6582-6591.
52. Zachary I., Morgan R.D. Therapeutic angiogenesis for cardiovascular disease: biological context, challenges, prospects. Heart 2011, 97:181-189.
53. Zhang L., Gao X., Wen J., Ning Y., Chen Y.G. Dapper 1 antagonizes Wnt signaling by promoting dishevelled degradation. J.Biol. Chem. 2006, 281:8607-8612.